Literature DB >> 8298648

Linkage mapping of dopa-responsive dystonia (DRD) to chromosome 14q.

T G Nygaard1, K C Wilhelmsen, N J Risch, D L Brown, J M Trugman, T C Gilliam, S Fahn, D E Weeks.   

Abstract

Dopa-responsive dystonia (DRD) is an autosomal-dominant neurological disorder which appears to result from a genetically determined deficiency of striatal dopamine. Pathological evidence suggests that this may be due to the establishment of a reduced number of dopaminergic nerve terminals in the striatum, or to an excessive reduction (pruning) of these terminals in early development. We have mapped the DRD gene to chromosome 14 by linkage analysis in 3 families with a maximum 2-point lod score of 4.67 at 8.6 centiMorgans from D14S63; maximum multipoint lod scores > 6 were obtained for the intervals D14S47-D14S52 and D14S52-D14S63. The flanking loci D14S47 and D14S63 define a region of about 22 cM as containing the DRD gene.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298648     DOI: 10.1038/ng1293-386

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  31 in total

1.  Linkage/association study of a locus modulating total serum IgE on chromosome 14q13-24 in families with asthma.

Authors:  A H Mansur; D T Bishop; S T Holgate; A F Markham; J F J Morrison
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

2.  GTP cyclohydrolase I mutations in patients with dystonia responsive to anticholinergic drugs.

Authors:  P R Jarman; O Bandmann; C D Marsden; N W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-09       Impact factor: 10.154

Review 3.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

4.  A novel mutation in GCH-1 gene in a case of dopa-responsive dystonia.

Authors:  Anna De Rosa; Carla Carducci; Italo Antonozzi; Teresa Giovanniello; Evgjeni Xhoxhi; Chiara Criscuolo; Valeria Menchise; Salvatore Striano; Alessandro Filla; Giuseppe De Michele
Journal:  J Neurol       Date:  2007-04-06       Impact factor: 4.849

5.  Paroxysmal dystonic choreoathetosis: tight linkage to chromosome 2q.

Authors:  J K Fink; S Rainer; J Wilkowski; S M Jones; A Kume; P Hedera; R Albin; J Mathay; L Girbach; T Varvil; B Otterud; M Leppert
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

Review 6.  The dystonias.

Authors:  P R Jarman; T T Warner
Journal:  J Med Genet       Date:  1998-04       Impact factor: 6.318

Review 7.  GTP cyclohydrolase I gene, tetrahydrobiopterin, and tyrosine hydroxylase gene: their relations to dystonia and parkinsonism.

Authors:  T Nagatsu; H Ichinose
Journal:  Neurochem Res       Date:  1996-02       Impact factor: 3.996

8.  GCH1 heterozygous mutation identified by whole-exome sequencing as a treatable condition in a patient presenting with progressive spastic paraplegia.

Authors:  Zheng Fan; Robert Greenwood; Ana C G Felix; Yael Shiloh-Malawsky; Michael Tennison; Myra Roche; Kristy Crooks; Karen Weck; Kirk Wilhelmsen; Jonathan Berg; James Evans
Journal:  J Neurol       Date:  2014-02-08       Impact factor: 4.849

Review 9.  Treatment strategies for dystonia.

Authors:  Leslie J Cloud; H A Jinnah
Journal:  Expert Opin Pharmacother       Date:  2010-01       Impact factor: 3.889

Review 10.  Neurogenetic diseases: molecular diagnosis and therapeutic approaches.

Authors:  U Muller; M B Graeber
Journal:  J Mol Med (Berl)       Date:  1996-02       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.